2016 Annual Meeting | Child Neurology II
| 01:00 PM - 01:10 PM |
Introduction and Overview
|
|
| 01:10 PM - 02:05 PM |
Neurogenetic Testing in Children
Alexander Paciorkowski, MD |
|
| 02:05 PM - 03:00 PM |
Newer Options for Treating Epilepsy in Children
Howard P. Goodkin, MD, PhD, FAAN |
| Jonathan W. Mink, MD, PhD, FAAN | The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS. |
| Howard P. Goodkin, MD, PhD, FAAN | Dr. Goodkin has received research support from NIH. Dr. Goodkin has received publishing royalties from a publication relating to health care. |
| Alexander Paciorkowski, MD | The institution of Dr. Paciorkowski has received research support from University of Rochester. |